Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
10h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
11h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
13h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
20h agoBuffalo Potash Files Annual Information Form and New Technical Report
21h agoIonik Announces 30-Day Extension of Senior Debt Facility
Abcellera Biologics Inc. logo

Abcellera Biologics Inc.

About

5.20USD+0.06 +1.17%
Closed • Updated at 00:16 GMT+00:00
Market Cap$1.59B
Volume6.47M
Beta2.88
RSI63.79
Gross Margin61.02%
Health TechnologyBiotechnology

Abcellera Biologics Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 11 2026
AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635
May 7 2026
AbCellera to Present at Upcoming Investor Conferences in May and June 2026
Apr 20 2026
AbCellera to Highlight Phase 1 Clinical Data for ABCL635 During Upcoming First Quarter 2026 Earnings Call
Apr 1 2026
AbCellera to Report First Quarter 2026 Financial Results on May 11, 2026
Feb 24 2026
AbCellera Reports Full Year 2025 Business Results

Community Chat

Ask AI

Try asking
6ix6ixAIEvents